News
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Science Featured on MSN6h
Popular Diabetes Drug Linked to Rare Vision Loss in New StudyResearch shows semaglutide, for diabetes and weight loss, may slightly increase vision risk, linked to a rare condition causing sudden, irreversible vision loss from optic nerve damage.
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...
Medicare coverage of obesity medications could drive a substantial rise in healthcare spending, according to a new study. A microsimulation model published in JAMA Health Forum projected that Medicare ...
Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...
Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
Trump Recasts Justice Dept. Civil Rights Office’s Mission, Prompting ‘Exodus’ Hundreds are leaving the arm of the agency that defends constitutional rights, which appointees intend to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results